Reliable Detection of Atrial Fibrillation with a Medical Wearable during Inpatient Conditions
- PMID: 32993132
- PMCID: PMC7583973
- DOI: 10.3390/s20195517
Reliable Detection of Atrial Fibrillation with a Medical Wearable during Inpatient Conditions
Abstract
Atrial fibrillation (AF) is the most common arrhythmia and has a major impact on morbidity and mortality; however, detection of asymptomatic AF is challenging. This study sims to evaluate the sensitivity and specificity of non-invasive AF detection by a medical wearable. In this observational trial, patients with AF admitted to a hospital carried the wearable and an ECG Holter (control) in parallel over a period of 24 h, while not in a physically restricted condition. The wearable with a tight-fit upper armband employs a photoplethysmography technology to determine pulse rates and inter-beat intervals. Different algorithms (including a deep neural network) were applied to five-minute periods photoplethysmography datasets for the detection of AF. A total of 2306 h of parallel recording time could be obtained in 102 patients; 1781 h (77.2%) were automatically interpretable by an algorithm. Sensitivity to detect AF was 95.2% and specificity 92.5% (area under the receiver operating characteristics curve (AUC) 0.97). Usage of deep neural network improved the sensitivity of AF detection by 0.8% (96.0%) and specificity by 6.5% (99.0%) (AUC 0.98). Detection of AF by means of a wearable is feasible in hospitalized but physically active patients. Employing a deep neural network enables reliable and continuous monitoring of AF.
Keywords: atrial fibrillation; clinical trial; deep neural network; photoplethysmography; wearable sensors.
Conflict of interest statement
The author declares that there is no conflict of interest. This trial was an Investigator Initiated Trial. This study used the wearable “Everion”-Device provided by Biovotion AG, Switzerland. Biovotion did not provide any financial support for the research and had no impact on writing of the manuscript. Biovotion did not participate in the analysis of the data or influence the conclusions in any sense.
Figures






References
-
- Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E.J., Gillum R.F., Kim Y.-H., McAnulty J.H., Zheng Z.-J., et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2013;129:837–847. doi: 10.1161/CIRCULATIONAHA.113.005119. - DOI - PMC - PubMed
-
- Benjamin E.J., Blaha M.J., Chiuve S.E., Cushman M., Das S.R., Deo R., de Ferranti S.D., Floyd J., Fornage M., Gillespie C., et al. Heart Disease and Stroke Statistics–2017 Update: A Report From the American Heart Association. Circulation. 2017;135:e146–e603. doi: 10.1161/CIR.0000000000000485. - DOI - PMC - PubMed
-
- Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., Castellá M., Diener H.-C., Heidbuchel H., Hendriks J., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. J. Cardio-Thorac. Surg. 2016;50:e1–e88. doi: 10.1093/ejcts/ezw313. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical